University of Birmingham‘s infectious disease reagent producer Native Antigen Company has been acquired in a deal enabling Mercia Asset Management to exit.

Highland Europe led a $25.2m round for the funeral and probate services provider, which also counts Daily Mail and General Trust among its investors.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chalmers Ventures head of startups Stina Linge will leave on September 2 to head up Lipidor's animal health products unit Emollivet.

Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.

Lundbeckfonden Ventures took a board seat at VarmX as part of a $36.2m round that will fund development of a treatment for spontaneous bleeding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Software analysis product developer LeanIX has now secured $120m altogether, Deutsche Telekom Capital Partners returning for its latest funding.

Pfizer Ventures joined Mission’s other existing investors to push the mitochondria-focused drug developer’s lifetime funding to approximately $143m.

Amgen-backed immuno-oncology spinout Immatics has gone public through a reverse merger with special purpose acquisition company Arya Sciences.